We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+563.35%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
-$247K
Cap. Flow %
-0%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
485
Reduced
534
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EA icon
576
Electronic Arts
EA
$52.9B
$1.33M 0.01%
15,534
+339
+2% +$27.1K
VBR icon
577
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
$1.33M 0.01%
11,990
+4,104
+52% +$450K
DOC icon
578
Healthpeak Properties
DOC
$15B
$1.32M 0.01%
38,072
-7,130
-16% -$249K
HCCI
579
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$1.31M 0.01%
98,735
-10,409
-10% -$134K
TCMD icon
580
Tactile Systems Technology
TCMD
$676M
$1.31M 0.01%
+69,863
New +$1.07M
AVB icon
581
AvalonBay Communities
AVB
$27.1B
$1.29M 0.01%
7,284
-255
-3% -$45.9K
WMB icon
582
Williams Companies
WMB
$87.8B
$1.29M 0.01%
41,913
+7,645
+22% +$203K
DTE icon
583
DTE Energy
DTE
$29.1B
$1.28M 0.01%
16,043
-570
-3% -$46.4K
TRI icon
584
Thomson Reuters
TRI
$43B
$1.27M 0.01%
26,542
+1,567
+6% +$75.9K
ENB icon
585
Enbridge
ENB
$113B
$1.27M 0.01%
28,668
+4,018
+16% +$168K
MINT icon
586
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$1.26M 0.01%
12,446
WWD icon
587
Woodward
WWD
$22B
$1.25M 0.01%
20,072
-428
-2% -$25.7K
ELS icon
588
Equity Lifestyle Properties
ELS
$12.6B
$1.25M 0.01%
32,388
-1,110
-3% -$44.1K
BP icon
589
CALL
BP
BP
$106B
$1.25M 0.01%
+42,192
New +$1.22M
SILC icon
590
Silicom
SILC
$254M
$1.24M 0.01%
+30,050
New +$1.12M
AZN icon
591
AstraZeneca
AZN
$250B
$1.24M 0.01%
18,880
-120
-0.6% -$7.84K
RBA icon
592
RB Global
RBA
$17.8B
$1.24M 0.01%
35,355
+3,660
+12% +$119K
DFS
593
DELISTED
Discover Financial Services
DFS
$1.24M 0.01%
21,895
-2,105
-9% -$121K
HSBC icon
594
HSBC
HSBC
$352B
$1.24M 0.01%
36,376
-4,037
-10% -$127K
HEI.A icon
595
HEICO Corp Class A
HEI.A
$37.2B
$1.23M 0.01%
49,673
-11,814
-19% -$276K
TSN icon
596
Tyson Foods
TSN
$20.5B
$1.23M 0.01%
16,443
-2,278
-12% -$167K
EWH icon
597
iShares MSCI Hong Kong ETF
EWH
$1.22B
$1.22M 0.01%
+55,191
New +$1.16M
NFG icon
598
National Fuel Gas
NFG
$7.5B
$1.21M 0.01%
22,370
+2,400
+12% +$136K
TLT icon
599
iShares 20+ Year Treasury Bond ETF
TLT
$41.8B
$1.21M 0.01%
8,800
-2,395
-21% -$332K
EWJ icon
600
iShares MSCI Japan ETF
EWJ
$22.5B
$1.2M 0.01%
23,955
-1,873
-7% -$91.2K

Similar funds

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 485 increased, 534 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.